This conference aims to disseminate cutting-edge findings on preclinical neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease. The event will provide a unique platform for specialists to come together across disciplines for an authoritative discussion of the methodological, regulatory, and ethical considerations of research in people at asymptomatic states of neurodegenerative disease.

The event will also have a translational focus, exploring genetic susceptibility, epidemiology and risk factors, neuronal vulnerability, biomarkers and early diagnosis, and disease prevention in healthy individuals with both pharmacological and non-pharmacological interventions.

Posters are invited by June 17, 2016 to supplement the invited oral programme which brings together more than 20 international experts.

Organising Committee
Elena Becker-Barroso, Editor, The Lancet Neurology
John Hardy, Department of Molecular Neuroscience, University College London
Jonathan Rohrer, Dementia Research Centre, University College London
Sarah Tabrizi, Institute of Neurology, University College London